3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Phase 4
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Stomach Neoplasms
1
Pancreatic Neoplasms
1
Frailty
1
Esophageal Neoplasms
1
Interventions
Metformin
16
Cyclophosphamide
16
Drug Therapy
14
Dexamethasone
14
Cisplatin
13
Cytarabine
11
Gemcitabine
10
Radiotherapy
9
Oxaliplatin
9
Carboplatin
9
Vincristine
8
Paclitaxel
8
Idarubicin
8
Etoposide
8
Docetaxel
8
ulipristal acetate
7
icotinib
7
Sodium Chloride
7
Methotrexate
7
Fluorouracil
7
Dexmedetomidine
7
entecavir
6
Thalidomide
6
Surgical Procedures, Operative
6
Sorafenib
6
Pemetrexed
6
Leuprolide
6
Granulocyte Colony-Stimulating Factor
6
Epirubicin
6
Doxorubicin
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Unknown
×
Immunonutrition Diet
×
Clear all
NCT03642093
2018-09-11
HOPE
Ochsner Health System
Phase 4
Unknown
60 enrolled